Navigation Links
Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available

Allergy Product in New Bubble Gum Flavor for Ages Two Years and Older

FT. WASHINGTON, Pa., Jan. 27 /PRNewswire/ -- McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., today announced the availability of Children's ZYRTEC(R) Allergy Bubble Gum Syrup, a new sugar-free, dye-free bubble gum flavor product used to treat perennial and seasonal allergic rhinitis, also known as upper respiratory allergies, in children ages two years and older. Children's ZYRTEC(R) Allergy Bubble Gum Syrup relieves kids' indoor and outdoor allergy symptoms. The new children's product is available in original prescription strength without a prescription in local retail stores starting today.

"The new sugar-free, dye-free children's allergy product offers the allergy relief of ZYRTEC(R) that parents have relied on for years, but without the addition of corn syrup or food dyes," said Rohinish Hooda, Vice President of Marketing, Upper Respiratory, McNeil Consumer Healthcare. "Children's ZYRTEC(R) Allergy Bubble Gum Syrup is an important addition to our pediatric portfolio to help parents manage their child's indoor and outdoor allergy symptoms."

Children's ZYRTEC(R) Allergy Bubble Gum Syrup, which is available in a convenient plastic bottle, received approval from the Food and Drug Administration in August 2008 to treat indoor and outdoor allergy symptoms for 24 hours. ZYRTEC(R) has a variety of products in different flavors and forms to help relieve children's allergy symptoms. These products are available in the original prescription strength without a prescription and include Children's ZYRTEC(R) Allergy Grape Syrup and sugar-free, dye-free Children's ZYRTEC(R) Allergy Bubble Gum Syrup for ages two years and older, as well as Children's ZYRTEC(R) Allergy Chewables for ages six years and older. ZYRTEC(R) also offers Children's ZYRTEC(R) Hives Relief Syrup for ages six years and older. For more information on Children's ZYRTEC(R) Allergy Bubble Gum Syrup and the portfolio of ZYRTEC(R) allergy products for adults and children, visit

About Allergies

More than 36 million Americans suffer from indoor and outdoor allergic rhinitis, also known as upper respiratory allergies. Up to 40 percent of children are affected by allergic rhinitis. In fact, on any given day, an estimated 10,000 American children miss school because of allergic rhinitis, for an annual total of two million lost school days. Allergies are caused when a person's immune system overreacts to normally harmless substances. These substances are often referred to as triggers. People can encounter indoor and outdoor allergy triggers anytime throughout the year that can lead to allergy symptoms. For children with allergies, the change of the seasons, sports, and even the school building itself can trigger symptoms like sneezing, runny nose and itchy-watery eyes.


ZYRTEC(R) is an antihistamine that helps block the action of histamine in the body. ZYRTEC(R) helps provide 24 hour relief of indoor and outdoor upper respiratory allergy symptoms including symptoms of sneezing, runny nose, and itchy-watery eyes. These symptoms can be caused by allergy triggers such as dust, mold and pet dander, tree pollen, weeds and grasses. ZYRTEC(R) offers a full line of products for adults, including ZYRTEC(R) tablets and ZYRTEC-D(R), as well as children. For more information about full line of ZYRTEC(R) products, visit

About McNeil Consumer Healthcare

McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., a subsidiary of Johnson & Johnson, markets a broad range of well-known and trusted over-the-counter (OTC) products. McNeil Consumer Healthcare is most widely recognized for the complete line of TYLENOL(R) acetaminophen products, the leading pain reliever brand in the adult and pediatric categories. The TYLENOL(R) product line consists of hundreds of products across a variety of pain categories including: arthritis pain, pain with accompanying sleeplessness and upper respiratory. Other McNeil Consumer Healthcare brands include BENADRYL(R) allergy medicine; IMODIUM(R) A-D anti-diarrheal; MOTRIN(R) IB; PediaCare(R) upper respiratory medicines for children; ROLAIDS(R) antacid products; ST. JOSEPH(R) Adult Regimen Aspirin; and SUDAFED(R) and SUDAFED PE(R) nasal decongestants.

    Teresa Panas                     Kathryn Ritzinger
    McNeil Consumer Healthcare       Cohn & Wolfe
    (908) 904-3198                   (212) 537-8217     

SOURCE McNeil Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
2. Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash
3. Siegel+Gale Designs New HOPE Portal for Childrens Hospital Los Angeles
4. Jessica Biel and Make The Difference Network Bring Holiday Cheer to Childrens Hospital Los Angeles
5. National Childrens Study Begins Recruiting
6. FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
8. Pollen, Fruits, Veggies Help Trigger Oral Allergy Syndrome
9. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
10. Clean to Ease Allergy and Asthma Symptoms
11. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
Post Your Comments:
(Date:11/28/2015)... , ... November 28, 2015 , ... Pixel Film Studios ... media panels to choose from, the possibilities are endless. Users have full control over ... the ProPanel: Pulse masking effects, users are sure to get heads to turn. , ...
(Date:11/27/2015)... ... , ... The rapid speed at which Americans are aging ... is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming more prevalent. ... part of this equation: 80 percent of medical care occurs in the home, ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with ... digital component is distributed nationally, through a vast social media strategy and across ...
(Date:11/27/2015)... ... ... A simply groundbreaking television series, "Voices in America", which is hosted by Hollywood legend, ... that are presently affecting Americans. Dedicated to providing the world with a wide variety ... consumers focus on, one episode at a time. , In the latest installment ...
(Date:11/27/2015)... ... , ... Dr. Thomas Dunlap and Dr. Patrick Coleman , ... Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , co-hosted ... similar ways and require time-critical intervention to avoid large area heart damage and progressive ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie ... ) --> ... (Photo: ) ... Medisch Centrum (LUMC) blijkt ...
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
(Date:11/26/2015)... --> ... att använda SyMRI för att hitta optimal ... med multipel skleros (MS) eller hjärntumörmetastaser och ... för att kunna använda SyMRI Research Edition ... kan man generera flera konstrastbilder från en ...
Breaking Medicine Technology: